Castle Biosciences, Inc. (CSTL)
NASDAQ · Healthcare
Castle Biosciences, Inc. annual/quarterly long term debt history from 2018 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Castle Biosciences, Inc. long term debt for the quarter ending December 31, 2025 were 10.1M, a 0.34% increase year-over-year.
- Castle Biosciences, Inc. long term debt for 2025 were 10.1M, a 0.34% increase from 2024.
- Castle Biosciences, Inc. long term debt for 2024 were 10.0M, a 62.44% decrease from 2019.
- Castle Biosciences, Inc. long term debt for 2019 were 26.7M, a 8.93% increase from 2018.
- Castle Biosciences, Inc. long term debt for 2018 were 24.5M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Castle Biosciences, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $10 |
| 2024 | $10 |
| 2019 | $27 |
| 2018 | $25 |
| Castle Biosciences, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $10 |
| 2024-12-31 | $10 |
| 2019-12-31 | $27 |
| 2018-12-31 | $25 |
Castle Biosciences, Inc. Long Term Debt — FAQ
Castle Biosciences, Inc. (CSTL) long term debt over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CSTL's long term debt history?
The chart and table above show Castle Biosciences, Inc.'s long term debt by year and by quarter, including the growth rate.